Brief: Clearside Biomedical Arctic Vision Says New Drug Applications For Arcatus Officially Accepted In Australia And Singapore

Clearside Biomedical,

29/07/2024 21:36

July 29 (Reuters) - Clearside Biomedical Inc  CLSD.O :
    * CLEARSIDE BIOMEDICAL’S PARTNER ARCTIC VISION REPORTS
POSITIVE
TOPLINE RESULTS FROM PHASE 3 CLINICAL TRIAL OF ARCATUS® FOR
SUPRACHOROIDAL USE IN UVEITIC MACULAR EDEMA PATIENTS IN CHINA
    * CLEARSIDE BIOMEDICAL: ARCTIC VISION ANNOUNCED THAT NEW
DRUG
APPLICATIONS FOR ARCATUS HAVE BEEN OFFICIALLY ACCEPTED IN
AUSTRALIA AND SINGAPORE

Source text for Eikon:  ID:nGNX6vG1XD 
Further company coverage:  CLSD.O 

 ((Reuters.Briefs@thomsonreuters.com;))